Herpes zoster

New England Journal of Medicine

Volumn 347, Issue 5, 2002, Pages 340-346

  Gnann Jr , John W ^a,b,c,d   Whitley, Richard J ^a,b  

^a Departments of Medicine   (United States)

^b Department of Microbiology ^*  (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CAPSAICIN; CORTICOSTEROID; DESIPRAMINE; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; NORTRIPTYLINE; OPIATE; OXYCODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; ATAXIA; CASE REPORT; CHICKENPOX; CONFUSION; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HEADACHE; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; MALAISE; MALE; NYSTAGMUS; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SKIN IRRITATION; SOMNOLENCE; VERTIGO; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEURALGIA; REVIEW;

ADRENAL CORTEX HORMONES; AGED; ANTIVIRAL AGENTS; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HIV SEROPOSITIVITY; HUMANS; MALE; NEURALGIA;

EID: 0036682163     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp013211     Document Type: Article

References (53)

1. Recent advances in varicella-zoster virus infection
2. The epidemiology of varicella and its complications
3. The incidence of herpes zoster
4. Population-based study of herpes zoster and its sequelae
5. Risk of cancer after herpes zoster: A population-based study
6. Herpes zoster and human immunodeficiency virus infection
7. Antigen detection: The method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patient
8. Neurologic complications of the reactivation of varicella-zoster virus
9. Postherpetic neuralgia - Pathogenesis, treatment, and prevention
10. Risk factors for postherpetic neuralgia
11. The outcome of patients with herpes zoster
12. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials
13. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
14. Natural history and treatment of varicella-zoster virus in high-risk populations
15. Rapidly progressive herpetic retinal necrosis: A blinding disease characteristic of edvanced AIDS
16. Therapy of herpes zoster with oral acyclovir
17. Oral acyclovir in the treatment of herpes zoster in general practice
18. Oral acyclovir in acute herpes zoster
19. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia: A randomized, double blind, placebo-controlled trial
20. Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of val acyclovir and famciclovir therapy in immunocompetent patients 50 years and older
21. Observations on the natural history of herpes zoster ophthalmicus
22. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus
23. Oral acyclovir for herpes zoster ophthalmicus
24. Famciclovir for ophthalmic zoster: A randomized aciclovir controlled study
25. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus
26. Varicella zoster viral disease
27. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus
28. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus infected patients: Results from a randomized, controlled clinical trial
29. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection
30. A mixed model for factors predictive of pain in AIDS patients with herpes zoster
31. A randomized trial of acyclovir for 7 days and 21 days with and without prednisolone for treatment of acute herpes zoster
32. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial
33. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia
34. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients
35. Treatments for postherpetic neuralgia - A systematic review of randomized controlled trials
36. Treatment of postherpetic neuralgia: An update
37. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia
38. Desipramine relieves postherpetic neuralgia
39. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
40. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia
41. Topical capsaicin treatment of chronic postherpetic neuralgia
42. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study
43. Intrathecal methylprednisolone for intractable postherpetic neuralgia
44. Herpes zoster: Risk categories for persistent pain
45. Treatment of acute herpes zoster: Effect of early (<48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain
46. Factors influencing pain outcome in herpes zoster: An observational study with valaciclovir
47. Lack of effect of acyclovir on postherpetic neuralgia
48. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia
49. Des treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?
50. Pain and its persistence in herpes zoster
51. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial
52. Use or a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect
53. Immunization to reduce the frequency and severity of herpes zoster and its complications